XPhyto Therapeutics (XPHY.C) Signs Acquisition Agreement with 3a-Diagnostics, Enters Biosensor Market
XPhyto Therapeutics (XPHY.C) announced today that it has signed a definitive agreement for the acquisition of 3a-Diagnostics GmhB, Frickenhausen, Germany, XPhyto’s exclusive diagnostic development partner.… Read More »XPhyto Therapeutics (XPHY.C) Signs Acquisition Agreement with 3a-Diagnostics, Enters Biosensor Market

